Abstract

The 1st Workshop of the Canadian Society for Virology (CSV2016) was a Special Workshop of the 35th Annual Meeting for the American Society for Virology, held on 18 June 2016 on the beautiful Virginia Tech campus in Blacksburg, Virginia. The workshop provided a forum for discussion of recent advances in the field, in an informal setting conducive to interaction with colleagues. CSV2016 featured two internationally-renowned Canadian keynote speakers who discussed translational virology research; American Society for Virology President Grant McFadden (then from University of Florida, now relocated to Arizona State University) who presented his studies of oncolytic poxviruses, while Matthew Miller (McMaster University) reviewed the prospects for a universal influenza vaccine. The workshop also featured a variety of trainee oral and poster presentations, and a panel discussion on the topic of the future of the CSV and virus research in Canada.

Highlights

  • Canadian virologists, including world-renowned experts in basic, clinical and epidemiological research, have made important contributions to our fundamental understanding of many viruses, which has led to the development of new strategies for monitoring, preventing and treating viral diseases

  • Well known the leading expert on a rabbit poxvirus known as myxoma virus, to McFadden has elucidated many as aspects of virus–host interactions, linking key poxvirus proteins immune has elucidated many aspects of virus–host interactions, linking key poxvirus proteins to evasion and pathogenesis [1]

  • dual specificity phosphatase 1 (DUSP1)-mediated inhibition of mitogen-activated protein kinase (MAPK) phosphorylation had no effect on downstream phosphorylation of activating transcription factor 2 (ATF2)/c-Jun, or the levels of cytokines elicited during infection

Read more

Summary

Introduction

Canadian virologists, including world-renowned experts in basic, clinical and epidemiological research, have made important contributions to our fundamental understanding of many viruses, which has led to the development of new strategies for monitoring, preventing and treating viral diseases. For Canada to meet the challenge of emerging and chronic viral infections, and realize its potential to lead in this research area, the virology research community must come together to exchange ideas and discover new opportunities for collaboration. To launch the CSV, we developed a Special Workshop in conjunction with the 35th Annual Meeting for the American Society for Virology. This workshop was the first scientific activity of the newly-founded CSV. To highlight diversity and excellence of Canadian virology research; to mobilize Canadian virus researchers across different disciplines (basic, clinical, social and epidemiological) to create a broader base of research expertise committed to tackling new challenges

Bunnies to Bone Marrow: ex vivo Virotherapy with Myxoma Virus
Control of MAP Kinase Signal Transduction during Paramyxovirus Infection
Control of Hepatitis C Virus Replication by MicroRNAs
Monitoring and Visualizing RNA Virus Evolution
CD8 T Cell Responses that Promote Protective Immunity to HCV Infection
Molecular Mechanisms of HIV Suppression of Antigen Presentation
Host-Targeted Antiviral Drug Discovery for Ebola Virus
10. Broadly-Neutralizing Antibodies against Influenza A Virus
11. Driving Forces for Aleutian Mink Disease Virus Evolution
12. Eliciting Neutralizing Antibodies for HCV Vaccine Development
Conclusions
Findings
Presentation

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.